Pharma & Healthcare
Tumor Necrosis Factor (TNF) Antagonists
- Types
- Adalimumab · Golimumab · Becelizumab
- Applications
- Hospital · Clinic · Other
5 editions29 December 2025
$4,950Single user · USD · Market Analysis & ForecastExplore product: Tumor Necrosis Factor (TNF) AntagonistsCompare research options for Tumor Necrosis Factor (TNF) Antagonists